Summary by Futu AI
On November 6, 2024, Nick Leschly, associated with bluebird bio, Inc. [BLUE], completed a transaction involving the direct acquisition of 24,900 shares of common stock at no cost. Following this transaction, Leschly's direct holdings in the company increased to a total of 315,839 shares. Additionally, Leschly holds an indirect interest in 168,699 shares through entities such as the Nick Leschly 2001 Trust and the Nick Leschly Irrevocable GST Trust of 2019. The nature of the transaction was classified as a grant, which typically indicates an award or acquisition related to compensation or incentive programs.